Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Ginkgo Bioworks Holdings, Inc. DNA

Set alert

Price alert · DNA

All alert types
10.43 USD +0.58 +5.89%

As of Nov 3, 1:26 PM ET

Bid
10.42 × 3
Ask
10.45 × 1
10.03 Day range 10.78
5.37 52-week range 18.22
YTD
+25.51%
1 year
-18.45%
Open
10.06
Prev close
9.85
Mkt cap
701.69M
Vol
1.12M
Avg vol
2.26M
EPS
-5.06
P/E
0.00
Div yield
0.00%
More statistics
Low
10.03
High
10.78
Forward P/E
-5.17
Beta
1.79
Short ratio
6.35
Inst. own
73.73%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
8.08
200-d avg
8.32
1y target
7.00

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 5, 2026Earnings: -0.75; estimate -0.895; surprise 16.2%
  • Aug 7, 2026Downgrade: TD Cowen · Buy → Hold
  • Sep 4, 2026Rating: BTIG · Sell → Sell
Signals (14)
NameDateAgo
SMA: BearishNov 2, 20261 day ago
MACD: Sell SignalNov 2, 20261 day ago
MACD: Buy SignalOct 29, 20265 days ago
SMA: BullishOct 27, 20261 week ago
SMA: BearishOct 20, 20262 weeks ago
MACD: Sell SignalOct 13, 20263 weeks ago
RSI: OverboughtSep 24, 20261 month ago
RSI: OverboughtSep 22, 20261 month ago
SMA: BullishSep 17, 20261 month ago
SMA: BullishSep 17, 20261 month ago
MACD: Buy SignalAug 25, 20262 months ago
MACD: Sell SignalAug 11, 20262 months ago
SMA: BearishAug 6, 20262 months ago
SMA: BearishAug 6, 20262 months ago

Analyst view

Price target (mean) 7.00 -32.9% downside
Target (low)
5.00
Target (mean)
7.00
Target (high)
9.00
Ratings (0m) 3 0 buy · 1 hold · 2 sell
  • Strong buy0
  • Buy0
  • Hold1
  • Sell1
  • Strong sell1

Recommendation trend

  • This month 3
  • 1 month ago 3

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

DNA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.58-0.58 – -0.580.000.0%21.58M-44.4%1
Next quarter-0.82-0.82 – -0.82-1.42+42.3%23.85M-28.6%1
Current year-3.20-3.20 – -3.20-3.66+12.5%85.03M-50.0%1
Next year-2.90-2.90 – -2.90-3.20+9.4%96.40M+13.4%1

Upgrades and downgrades

The latest rating changes

DNA analyst upgrades and downgrades
DateFirmActionFromTo
Sep 4, 2026BTIGReiteratedSellSell
Aug 7, 2026TD CowenDowngradeBuyHold
Mar 12, 2026BTIGMaintainedSellSell
Jan 8, 2026TD CowenMaintainedBuyBuy
Aug 25, 2025BTIGMaintainedSellSell
Sep 20, 2024TD CowenMaintainedBuyBuy
Aug 23, 2024BTIGMaintainedSellSell
Jul 9, 2024Goldman SachsMaintainedSellSell
Jun 26, 2024BTIGMaintainedSellSell
May 15, 2024BTIGDowngradeNeutralSell
May 15, 2024Morgan StanleyMaintainedEqual-WeightEqual-Weight
May 10, 2024William BlairDowngradeMarket PerformUnderperform
Mar 1, 2024TD CowenMaintainedOutperformOutperform
Jan 23, 2024Goldman SachsMaintainedSellSell
Jan 22, 2024Goldman SachsMaintainedSellSell
Nov 15, 2023Raymond JamesDowngradeOutperformMarket Perform
Nov 14, 2023Raymond JamesDowngradeOutperformMarket Perform
Nov 9, 2023BTIGDowngradeBuyNeutral
Jun 5, 2023Goldman SachsMaintainedSellSell
Jun 2, 2023Goldman SachsDowngradeNeutralSell
May 11, 2023William BlairDowngradeOutperformMarket Perform
Nov 29, 2022BerenbergInitiated—Buy
Oct 4, 2022Morgan StanleyInitiated—Equal-Weight
Aug 16, 2022BTIGMaintained—Buy
Aug 16, 2022Raymond JamesMaintained—Outperform
Jun 16, 2022JefferiesMaintained—Buy
May 18, 2022B of A SecuritiesDowngradeNeutralUnderperform
Mar 2, 2022Cowen & Co.Initiated—Outperform
Feb 23, 2022Goldman SachsInitiated—Neutral
Feb 1, 2022B of A SecuritiesInitiated—Neutral